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One hundred twenty-nine adult patients who received 
an orthotopic liver transplantation and survived at least 
24 hr after surgery were evaluated. During the period 
of follow-up, 48 of the 129 patients (37%) died. Only 40 
of these 48 patients died at our institution and were 
included in this study. Seventeen of the 40 deaths 
(42.5%) occurred during the first month after orthotopic 
liver transplantation and 30 of the 40 deaths (75%) 
occurred during the first 60 days post-orthotopic liver 
transplantation. Death was related to infection in 21 
cases (52.5%), to multiorgan failure in 8 (20%) and to 
uncontrollable rejection in 3 (7.6%). The remaining 
eight deaths (20%) were attributed to a variety of other 
causes. Eleven of the 21 deaths related to infection (52%) 
occurred during the first month after orthotopic liver 
transplantation. Bacterial sepsis was the leading cause 
of death and accounted for 17 of the 21 deaths (81 %) in 
which infection was present at the time of death. The 
most frequently isolated bacteria were Pseudomonas 
and other enteric Gram-negative bacilli. Three patients 
had complete occlusion of the hepatic artery of the 
grafted liver. Six patients developed massive infarction 
of the liver despite patent vascular anastomoses. Histo-
logical signs of rejection were seen in 9 of the 31 patients 
autopsied (29%), but in only 3 of these (9.6%) was rejec-
tion the principal cause of death. The biliary anasto-
moses were patent in all 31 cases examined at autopsy. 
Due to a variety of factors, including better initial 
selection of candidates for the procedure, refinements in 
the techniques of organ procurement and surgical graft-
ing, the introduction of cyclosporine A and improve-
ments in the pre- and postoperative management of such 
patients, the life expectancy of patients undergoing or-
thotopic liver transplantation (OLTx) has increased con-
siderably in the last several years (1-4). As a result of 
these improvements and their effects upon patient sur-
vival, liver transplantation has become a widely prac-
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ticed, albeit sophisticated and heroic, mode of therapy 
for individuals with otherwise terminal liver disease (3, 
4). As survival following transplantation continues to 
improve, OLTx is being performed at more and more 
centers all over the world. 
An analysis of the causes of death after OLTx, using 
cyclosporine A as the principal immunosuppressive drug, 
would appear therefore to be quite timely. It is hoped 
that this information will be useful to those centers which 
are performing the procedure presently and to those 
which are interested in starting a liver transplantation 
program in the near future. 
PATIENTS AND METHODS 
One hundred thirty-six consecutive adult patients who re-
ceived an OL Tx at the University of Pittsburgh between March, 
1981 and July, 1984 were evaluated. Thirty-one of these pa-
tients received two successive transplants, and five received 
three. One patient who had received her first OL Tx elsewhere, 
but who died at the University of Pittsburgh, was excluded 
from the analysis. Only patients who survived the immediate 
postoperative period (24 hr) were included in the study. Thus, 
seven patients who did not survive the required 24 hr after 
surgery were excluded from the analysis, leaving a total of 129 
patients for evaluation. These excluded patients all died in the 
operating room or within several hours of leaving the operating 
room and were, for all practical purposes, "operative" deaths. 
Most (five) died of exsanguination, 1 died of a pulmonary 
embolus and 1 experienced an intraoperative cardiac arrest and 
could not be resuscitated. 
The details of our patient selection method, surgical proce-
dure, immunosuppressive regimen and supportive care have 
been described in detail previously (3-5). All OL Tx recipients 
received comparble clinical management from the same medical 
and surgical teams. 
The indications for transplantation in these 129 patients are 
shown in Table 1. The survival data for all patients have been 
updated to August, 1984. During the period of follow-up, 49 of 
the 129 patients have died (37%). Only 40 of these 48 patients 
died at the University of Pittsburgh and were included in this 
study. For 31 of the total 48 deaths (65%), autopsy reports were 
available, all from the University of Pittsburgh. Complete au-
topsies were performed in 21. Autopsy data excluding an ex-
amination of the brain, eyes and spinal cord were available in 
eight additional cases. In two cases, the autopsy was limited to 
the abdomen. In each of these 31 cases, the autopsy provided 
definitive data about the cause of death. In the remaining nine 
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TABLE 1. Characteristics of the patients studied 
Patients 
Liver disease Total 
Alive Dead p 
Age (yr) M/F Age (yr) M/F n Age (yr) M/F n Mean ±S.E. ratio n Mean ± S.E. ratio Mean ± S.E. ratio 
Post necrotic disease 36 32.5 ± 1.6 22/14 22 31.4 ± 2.0 13/9 14 34.3 ± 2.5 9/5 NS 
Primary biliary cirrhosis 34 44.1 ± 0.9 0/34 24 41.2 ± 0.9 0/24 10 41.6 ± 1.9 0/10 NS 
Sclerosing cholangitis 21 33.8 ± 1.9 12/4 15 35.8 ± 2.2 12/3 6 28.6 ± 3.2 5/1 NS 
Hepatic malignancy' 15 32.1 ± 2.8 5/10 9 28.2 ± 2.6 3/6 6 37.8 ± 5.1 2/4 NS 
"I' Ant itrypsin deficiency 5 40.4 ± 3.7 4/1 1 44 1/9 4 39.5 ± 4.5 3/1 
Wilson's disease 4 29.0 ± 4.4 2/2 3 32.0 ± 4.6 2/1 1 20 0/1 
Acute fulminant hepatic fail- 4 31.5 ± 2.4 3/1 37 1/0 3 28.5 ± 2.9 2/1 
ure b 
Budd-Chiari's syndrome 3 33.0 ± 3.6 2/1 2 35.5 ± 4.5 2/0 1 28 0/1 
Secondary biliary cirrhosis 2 26.5 ± 4.6 1/1 32 I/O 22 0/1 
Caroli's disease 2 19 0/2 19 0/1 1 19 0/1 
Polycystic liver and kidney 42 0/1 1 42 0/1 
disease' 
Adenomas of the liverd 33 0/1 33 0/1 
Obstructive jaundice second- 23 I/O 1 23 1/0 
ary to cryptococcus cho-
langitis 
Total 129 35.6 ± 0.9 57/72 81 36.4 ± 0.1 35/46 48 37.2 ± 1.4 22/26 
NS = not statistically significant. 
a Including hepatocellular carcinoma (10 cases), fibrolamellar (3 cases), cholangiolar carcinoma (I case) and hemangiosarcoma (1 case). 
b Including two cases of toxic hepatitis (gold and methylethyl ketone, respectively) and two cases of viral non-A, non-B hepatitis. 
C Kidney transplant also performed in this patient. 
d This patient had had a previous hepatic trisegmentectomy. 
cases in which autopsy was not performed, the cause of death 
had to be determined using clinical criteria. 
Only one cause of death was identified for each patient 
studied. An infectious etiology was recognized as the cause of 
death if it was the major diagnosis established at autopsy or, in 
the cases in which no autopsy was performed, if infection was 
of primary importance in the patient's clinical management 
just prior to death. When a major infection coexisted with 
multiorgan failure or graft rejection, the cause of death was 
considered to be due to the infection, as the infection in such 
cases prohibited either more aggressive immunosuppression or 
retransplantation. A fungal infection was identified as the 
principal cause of death if it was demonstrated that tissue 
invasion had occurred and/or the fungal infection was the major 
clinical problem prior to the patient's death. 
The histologic criteria used for rejection have been described 
in detail elsewhere (6-8). Briefly, early rejection consists of a 
portal and/or lobular mixed inflammatory infiltrate, disruption 
of the limiting plate and a characteristic bile duct cell injury, 
with occasional portal and central vein endothelitis. Late rejec-
tion is defined either as a vascular injury of the medium-sized 
hilar arteries which demonstrate subendothelial foam cells, 
fibrinoid necrosis and intimal hyperplasia or extensive peripor-
tal bridging fibrosis associated with disappearance of the inter-
lobular bile ducts. 
RESULTS 
Cause of Death. The 40 adult subjects included in 
this study consisted of 24 females and 16 males. Their 
ages ranged from 18 to 52 years (33 ± 2 years; mean ± 
S.E.). The distribution of these 40 patients by age is 
shown in Figure 1. The overall mortality in this series 
was 37%. Because of small numbers and the many dif-
ferent causes of death possible, no differences were seen 
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FIG. 1. Age distribution of the 40 adult patients who died after liver 
transplantation. Open bars represent number of patients having a 
transplant for each 5-year period. Cross-hatched bars represent number 
dying foJlowng OL Tx. 
for the causes of deaths following OL Tx in patients 
operated upon for different underlying diseases. 
The principal causes of death identified in the 40 
patients who died following transplantation and an ini-
tial 24-hr postsurgical period are listed in Table 2. Al-
though only the primary cause of death is given for each 
case, other factors often contributed to a given patient's 
death. In fact, the cause of death in many cases was 
multifactorial. At times, it was difficult to determine 
which factor was the predominant factor responsible for 
a given patient's death. Generally, either the most prom-
inent pathological event found at autopsy or the most 
important complication during their immediate preter-
minal clinical course, if an autopsy was not performed, 
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TABLE 2. Principal cauS(' of death in the 40 consecutive adult patients studied who survived at least 24 br but ultimately died 
after liver transplantation 
Principle cause or death- n 
Infection b 21 
Multiorgan failure 8 
Rejection 3 
Massive GI bleeding 3 
Massive CNS hemorrhage 2 
Massive pulmonary bleeding 
Pulmonary thromboembo-
lism 
Hyperkalemia 
Total 40 
No 
12 
4 
2 
3 
0 
0 
0 
22 
Yes Cause of retransplantation 
9 Rejection (6) 
Thrombosis hepatic artery and mas-
sive hepatic infarction (3) 
4 Rejection (3) 
Thrombosis hepatic artery and mas-
sive hepatic infarction (1) 
1 Rejection 
o 
1 
18 
Thrombosis hepatic artery and mas-
sive infarction 
Acute rejection 
Extensive hepatic coagulative, necrosis 
Thrombosis hepatic artery, massive 
hepatic infarction and CMV 
hepatitis 
The abbreviations used are: GI = gastrointestinal; CNS = central nervous system; CMV = cytomegalovirus. 
a Only the principal cause of death for each patient studied has been included. When a major infection coexisted with multiorgan failure (5 
cases) or rejection (1 easel. the cause of death was considered to be due to infection (see text). 
b Including bacterial sepsis (13 cases). disseminated fungemia (2 cases), concomitant bacterial and fungal sepsis (4 cases), pulmonary fungemia 
(1 case) and disseminated herpes simplex virus infection'(1 case). 
was identified as the cause of death. As can be seen from 
Table 2, infection was the primary cause of death in 
52.5% of the deaths, multiorgan failure accounted for 
20% of the deaths and uncontrollable rejection and mas-
sive gastrointestinal bleeding each accounted for only 
7.5% of the deaths. The remaining five deaths (12.5%) 
were attributed to a variety of causes, which included 
one case of massive pulmonary bleeding due to dissemi-
nated intravascular coagulation; one case of pulmonary 
thromboembolism, and one case each of cerebral hem-
orrhage and subarachnoidal hemorrhage. In one patient, 
no specific cause of death was identified at autopsy, and 
the death was attributed to a cardiac arrest which was 
thought to have occurred as a result of hyperkalemia. 
TIle time interval between the initial OL Tx and the 
subsequent death of the patient was 46.4 ± 6.1 days 
(range == 4-296 days). The number of cases dying at a 
given time after OL Tx is shown in Figure 2. As can be 
seen, 17 of the 40 deaths (42.5 %) occurred during the 
first month after OL Tx, and a full 30 of the 40 deaths 
(75%) occurred during the first 60 days posttransplan-
tation. Among the 40 patients who died and were in-
cluded in this study, 18 (45%) had had a second OLTx 
(Table 2). The cause of death in these 18 cases did not 
differ in terms of the principal causes of death or fre-
quency of a given cause of death from those who received 
only a single transplant. Thus, the fact of a prior trans-
plant did not appear to alter the cause of death but did 
enhance the risk of death, probably as a consequence of 
progressive debilitation that was either not improved or 
more usually worsened as result of the earlier failed 
transplant (Table 2). 
Evidence of infection, often associated with septi-
cemia, was present in 21 of the 40 patients (52.5%) who 
died in this series. The number of patients who died 
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FIG. 2. Number of patients who subsequently died after liver trans-
plantation. distributed as to time of death posttranspiantation. 
because of an infectious disease at specific time intervals 
after liver transplantation is shown in Table 3. Bacterial 
sepsis was the leading infectious cause of death and 
accounted for 17 of the 21 deaths (81 %) in which infec-
tion was present at the time of death. In 4 of these 17 
patients, bacterial sepsis coexisted with disseminated 
fungal infection, but the bacterial sepsis was considered 
to be the cause of death. At all time intervals studied 
(Table 3), bacterial sepsis was more prevalent than fun-
gal sepsis. The latter tended to occur early rather than 
late following OLTx. 
A wide range of pathogenic organisms was identified 
in the 21 patients. The organisms recovered in cultures 
obtained postmortem are identified in Table 4. The 
various microbiological agents which were isolated from 
these 21 patients prior to their death, but which were 
not identified in the postmortem cultures are not in-
cluded in this table. The most frequently isolated bacte-
ria were Pseudomonas sp. with other enteric Gram-neg-
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TABLE 3. Number of patients who died because of an 
infectious disease after liver transplantation as a function of 
time posttransplantation 
Months after liver 
Types of infection transplantation 
0-1 1-2 2-3 3-4 
Bacterial sepsis 6 oS 1 1 
Concomitant bacterial, 3 0 0 
fungal sepsis 
Invasive disseminated fi ;'". 2 0 0 0 
mia 
Fungal pneumonia 0 0 0 
Disseminated herpE" Ini. 0 0 0 
infection 
Total 11 8 
(%)0 (52%) (38%) (5%) (5%) 
• Per cent of total infectious disease-related deaths. 
TABLE 4. Pathogenic organisms recovered in postmortem 
cultures in patients dying of an infectious disease after liver 
transplantation 
Bacteria 
Pseudomonas 
EnterobactPr 
mroteuI~ morgagni 
Escherichia coli 
Klebsiella pneumoniae 
Serratia marcescens 
Citerobacter freundii 
Streptococcus faecalis 
Fungi 
Aspergillus fumigatus 
Candida sp. 
Viruses 
Cytl1megalovirus 
Herpes simplex 
9 
2 
5 
3 
ative bacilli being second. Thus, infections due to Pseu-
dOmOnCL'i (aeruginosa and maltophilia) were present in 9 
of the 17 cases (53%) in which a bacterial infection was 
the primary cause of death. The enteric bacilli isolated 
in the other six cases were: Enterobacter (2 cases); Pro-
teus morgagni (1 case); Eschericia coli (1 case); Klebsiella 
(1 case), and Serratia marcescens (1 case). The principal 
sites of these bacterial infections were the lungs (pneu-
monia) in 7 cases (42%) and an intraabdominal site in 5 
(29%). In five cases, the principal site of the infection 
could not be identified. 
Disseminated fungal infection occurred in seven cases, 
and was the major cause of death in all seven. The 
etiologic agents isolated from these seven cases were 
Aspergillus (4 cases) and Candida sp. (3 cases). The 
specific sites of organ involvement in these cases of 
disseminated fungal infection are listed in Table 5. Dis-
seminated fungal infection coexisted with bilateral fun-
gal bronchopneumonia in 6 of these 7 cases. 
Disseminated herpes simplex virus infection was the 
main cause of death in a single patient who required a 
second transplant 9 days after his initial transplanted 
organ failed. Following the second transplantation, he 
had poor respiratory and renal function and developed a 
right pleural effusion, sepsis and decerebrate posturing. 
At autopsy, a severe necrotizing herpes simplex infection 
involving the larynx, tracheobronchial tree, right lobe of 
the lung, the urinary bladder, colon and liver was found. 
Pathological Findings in the Liver Allo-
grafts. The biliary anastomoses were patent in all 31 
cases examined at autopsy. The various vascular anas-
tomoses were intact and patent in 27 of the 31 patients 
studied (87%). Three patients had complete occlusion of 
the hepatic artery with resultant infarction of the grafted 
liver. Two of these three patients died because of infec-
tion (Pseudomonas aeruginosa septicemia and systemic 
candidiasis). The third patient had a streptokinase in-
fusion started prior to death and died as a result of 
gastrointestinal bleeding from ulceration and rupture of 
esophageal varices. One additional patient was found to 
have mural thrombi at the hepatic artery and inferior 
vena caval anastomoses and a sttnotic anastomosis of 
the portal vein. This patient also has an infarcted liver 
and died as a consequence of Pseudomonas aeruginosa 
sepsis. 
The pathological findings present in the liver in these 
31 patients are listed in Table 6. Histological evidence of 
rejection was present in 9 (29%), but in only 3 was the 
rejection process the principal cause of death. These 
three patients died on the 9th, 52nd and 159th post-
OL Tx day, respectively. Six patients developed massive 
infarction of the liver despite patent vascular anasto-
moses. Three of these died because of bacterial sepsis, 
and one died because of disseminated aspergillosis. No 
hepatic involvement of the sepsis process was evident in 
these four cases. In all six of these patients with massive 
hepatic infarction, hepatic failure was evident well before 
the death of the patient. All had had premorbid hypoten-
sion occurring as a response to their sepsis. In each case, 
hypotension management was limited because of pul-
monary and renal complications and failure to respond 
to vasopressors. The time latency between the initial 
OLTx procedure and death in these patients was 18.8 ± 
5.5 days. Focal necrosis and severe hepatic congestion 
with cholestasis was found in six patients. Massive ne-
TABLE 5. Organ involvement in seven patients who died after 
liver transplantation because of disseminated fungal infection 
Organ involved Aspergillus Candida sp. 
Brain 3 0 
Thyroid 4 1 
Heart 3 2 
Lung 4 2 
Liver 0 2 
Spleen 0 2 
Esophagus 1 
Stomach 2 1 
Duodenum 0 1 
Colon 1 0 
Peritoneum 1 1 
Kidney 2 2 
Urinary bladder 
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T ABl,E 6. Pathological rindings or the liver allograrts studied 
at autopsy in 31 patients who died after liver transplantation 
D % haviDg a lMlCond transplaDt 
Massive infarction" 10 0 
Rejection b 9 100 
Focal necrosis and severe he- 6 50 
patic congestion 
Chronic active hepatitis and 0 
cirrhosis' 
Small hepatic infarcts 1 '100 
Cytomegalovirus hepatitlb 1 0 
Herpes simplex hepatitis 1 0 
Minimal changes 2 50 
Total 31 
"Six of these 10 patients had patent vascular anastodJOses. Three 
patients had complete occlusion of the hepatic artery. Another patient 
had mural thrombi at the anastomoses of both the hepatic artery and 
inferior vena cava. 
b Severe rejection (3 cases) and mild to moderate rejection (6 cases). 
, This patient was HBsAg( +) before and after liver transplantation. 
crosis, chronic hepatitis and cirrhosis were found in the 
liver of one patient who died 150 days posttransplanta-
tion because of an intraabdominal hemorrhage. This 
patient was HBsAg positive before and after OLTx sur-
gery. Multiple small hepatic infarcts were seen in another 
patient who died of bacterial sepsis. One patient had 
severe cytomegalovirus hepatitis in the course of an 
overwhelming systemic cytomegalovirus infection, and a 
second patient died because of a disseminated herpes 
simplex virus infection, which included herpes simplex 
hepatitis. Minimal changes were found in the liver of the 
two other patients. 
Neuropathologic Findings. The brain was avail-
able for study in 21 of the 31 cases which were autopsied 
(68%). Central pontine myelinolysis, which is a focal 
symmetrical demyelination with preservation of neurons 
and the majority of the axon cylinders located in the 
basis pontis near the tegmentum which is thought to 
occur as a consequence of electrolyte abnormalities and 
their rapid correction, was found in 6 of the 21 brains 
studied (29%). Three of these cases died because of 
disseminated fungemia (Aspergillus twice and Candida 
sp. once). The other three patients with central pontine 
myelinolysis died because of central nervous system hy-
poxia and multi organ failure with widespread hepatic 
necrosis (2 cases) and Pseudomonas sepsis (1 case). 
In the three cases of aspergillosis involving the brain, 
the infection took the form of necrotizing hemorrhagic 
infarcts. Miscellaneous neuropathological findings in-
cluded the following; brain edema (4 cases); autolytic 
changes (4 cases); pituitary infarcts (3 cases), and one 
case of subarachnoid and intracerebral hemorrhage. 
DISCUSSION 
During the early years of liver transplantation, tech-
nical problems, mainly those related with the biliary 
tract anastomoses, were the major cause of recipient 
death and accounted for 39% of the 108 deaths in cases 
which were transplanted at the University of Colorado 
between 1963 and 1977 and have been reported previ-
ously (9). In contrast to this early series, technical prob-
lems accounted for only a minor percentage of the deaths 
in the present series. In fact, only 1 of the 129 patients 
(0.8%) who survived the first 24 hr after liver transplan-
tation reported in the present series died as a result of a 
technical problem. Specifically, this patient died as a 
result of massive gastrointestinal hemorrhage occurring 
as a result of an arteriocholedochal fistula. 
There are several reasons for this remarkable differ-
ence between these two series. These include improve-
ments in the surgical procedure, the skill accrued in its 
performance, a better preoperative evaluation and pa-
tient selection and earlier treatment of technical prob-
lems, once they are recognized. Until 1976, cholecys-
toduodenostomy was the main type of the biliary anas-
tomoses performed at the University of Colorado. With 
this type of biliary anastomoses, repeated bacterial con-
tamination of the biliary tree, with cholangitis and con-
sequent infection and death of the recipient was common 
(1-3, 9, 10). During these early years of clinical liver 
transplantation, most of the biliary tract complication 
were either unrecognized until late in the clinical course 
or at autopsy. This failure to recognize biliary tract sepsis 
in the earlier series was due principally to the many 
technical difficulties encountered by the physicians car-
ing for the patients in establishing a specific diagnosis 
of biliary tract sepsis in such complexly ill patients (9, 
10). Currently, biliary tract complications (particularly 
infection) are the initial diagnostic consideration in a 
liver transplant recipient who has an abnormal postop-
erative course. In fact, the transplant team at the U ni-
versity of Pittsburgh uses cholangiography as the initial 
step in the evaluation of any liver transplant patient who 
demonstrates an abnormal postoperative course. The 
current practice of creating a choledochocholedochos-
tomy as the biliary anastomosis using aT-tube stent and 
the ready availability of the resultant percutaneous limb 
of the stent makes cholangiography possible in the eval-
uation of all such patients. As a consequence, an earlier 
and more accurate diagnosis of biliary tree complications 
can be made and earlier surgical intervention, if it is 
required, can be accomplished. Furthermore, in selected 
patients, therapeutic interventional radiologic tech-
niques, such as dilatation of a biliary tract stricture, 
biliary stent removal and restoration of lumenal patency 
of an obstructed T-tube can be achieved rather easily. In 
the first 96 adult patients undergoing liver transplanta-
tion at the University of Pittsburgh, a biliary complica-
tion was diagnosed in 44 by cholangiography. These 
included 8 cases of obstruction, 24 cases of anastomotic 
biliary leak and 12 cases of assorted T -tube problems 
(11). 
The addition of newer noninvasive diagnostic imaging 
modalities (CT and ultrasound) as well as nuclear scin-
tigraphy and other more invasive radiologic tests (an-
giography) play important roles in the diagnosis of an-
astomotic technical problems. Moreover, the existence 
of a very active organ procurement program has made 
liver retransplantation possible in cases that are not 
otherwise salvageable. As a result, early retransplanta-
500 rt'ERYAS·MO:'\S ET AL. H':PATOI.O(;Y 
tion in patients with hepatic artery thrombosis is accom-
plished as soon as possible following diagnosis, thereby 
avoiding the otherwise fatal outcome of such patients 
experienced in earlier series. 
Transplanted tissues are subject to quite variable de-
grees of rejection. In the earlier series of deaths reported 
following liver transplantation, rejection was not consid-
ered to be a major problem (1, 2, 7,8). This difference in 
results between previous series and the one currently 
being reported may be due, at least in part, to the fact 
that in the earlier series only autopsy samples of liver 
were available for study. As a result, it was thought that 
immunosuppressive (;'. 'rtreatment was responsible for 
many of these deaths {~I 10). Since the introduction of 
cyclosporine A, a marked reduction in the incjdence of 
acute liver graft rejection episodes has been noted as 
compared to that experienced with earlier forms of im-
munosuppressive therapy (3). Thus, it might be thought 
that early graft rejection no longer occurs or is not an 
important problem in the clinical management of liver 
transplant recipients. For example, only 3 of the 40 
patients (7.5%) analyzed in the present study died as a 
direct effect of uncontrolled liver graft rejection. This 
low percentage of death caused directly by graft rejection 
does not mean, however that rejection is not an impor-
tant problem in these patients. On the contrary, liver 
allograft rejection is a frequent and important problem 
experienced by such patients, but because of organ avail-
ability, severe rejection when it occurs can be managed 
aggressively with retransplantation in most cases. 
Although the true incidence of liver rejection is diffi-
cult to ascertain, the rate of liver allograft rejection in a 
recent series without serial protocol liver graft biopsies 
was reported to be at least 37% (6). The actual incidence 
of liver allograft rejection is probably much greater. In 
this series, liver biosies were performed only when clini-
cally indicated. Thus in this series, the incidence of 
rejection was calculated with the assumption that rejec-
tion had not occurred in those patients in which speci-
mens were not available for examination (6). Obviously, 
this assumption may not be true in all cases as has been 
demonstrated when protocol biopsies have been obtained 
(7,8). 
Obviously, the primary treatment for liver allograft 
rejection is increased immunosuppression. The criteria 
for early retransplantation for uncontrollable liver graft 
rejection have been published elsewhere (12). Briefly, 
early retransplantation is attempted if, in the first month 
after grafting, the bilirubin level persists above 10 mg 
per dl, with or without an associated elevation of the 
transaminases, and it is unresponsive to two full courses 
of standard antirejection therapy. Any patient, regardless 
of serum bilirubin level, whose liver function deteriorates 
rapidly whenever the steroid dosage is reduced to ac-
ceptable maintenance levels (approximately 20 to 30 mg 
daily) or any patient who requires frequent intravenous 
bolus injections of steroids in an attempt to control rising 
transaminase levels is also a candidate for early retrans-
plantation. Using these criteria, liver graft rejection was 
considered to be uncontrollable with standard immuno-
suppressive regimens in 14 of our first 93 consecutive 
adult patients (15%) (unpublished data), with 11 of these 
14 patients (79%) being treated with early retransplan-
tation. The remaining three died before a new liver was 
available for retransplantation. All 14 of these patients 
presumably would have died if early retransplantation 
had not been performed. Therefore, as early retransplan-
tation appears to be the only chance for survival for such 
critically ill patients, we believe that the current ten-
dency to ascribe most of the mortality following liver 
transplantation to factors other than rejection (2, 3, 9, 
10, 13, 14) may not be entirely correct. 
While in our experience, technical problems and rejec-
tion have become lesser problems as the primary cause 
of death in liver transplant recipients, infection has 
become the major cause of mortality experienced by these 
patients. Thus in the present series, evidence of major 
infection, severe enough to have been responsible for the 
patient's death, was present in 52.5% of the cases. By 
far, bacterial sepsis and disseminated fungal infection 
were the most common cause of death in this series with 
Pseudomonas, other Gram-negative enteric bacilli, As-
pergillus and Candida sp. being the most common path-
ogenic organisms being isolated. Although problems of 
surgical technique have played a historical role in the 
pathogenesis ofthese infections complicating liver trans-
plantation, presently the basis for most is linked to the 
use of immunosuppressive agents either to treat or pre-
vent rejection (15-17). Thus, we believe the risk of fur-
ther attempts to rescue a severely injured or rejecting 
primary graft with additional immunotherapy and pos-
sible infection must be weighed against the risk of reop-
eration. In our opinion, failure to respond rapidly to 
intensified immunosuppression is an indication for re-
transplantation which should be attempted early rather 
than late in order to avoid unnecessary infections which 
are associated directly with enhanced immunosuppres-
sion. The vast majority of such infections, both bacterial 
and fungal, are recognized well before death. Moreover, 
most are treated with antibiotics selected on the basis of 
culture and sensitivity results. However, renal failure 
often limits the amounts used. Perhaps the routine use 
ofliver graft biopsy, the only reliable means for detecting 
graft rejection (7, 8, 18) in cases with negative findings 
at cholangiography, would result in a more accurate and 
timely diagnosis of graft rejection, decrease the amount 
of immunosuppressive drugs being administered to the 
patient in the vain hope of treating rejection when it is 
not present, and hopefully result, therefore, in a lower 
death rate. 
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